Perspective Therapeutics (CATX) Price to Sales (2010 - 2023)

Perspective Therapeutics has disclosed Price to Sales across 14 years of filings, most recently posting 23.0 for Q4 2023.

• In Q4 2023, Price to Sales changed N/A year-over-year to 23.0; the TTM figure through Dec 2023 stood at 78.61 (changed N/A YoY), while the FY2023 annual figure was 78.61, changed N/A from the prior year.
• Price to Sales came in at 23.0 for Q4 2023 at Perspective Therapeutics, down from 34.67 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 90.0 in Q2 2023 to a low of 23.0 in Q4 2023.
• Average Price to Sales over 5 years is 24.51, with a median of 16.93 recorded in 2020.
• Year-over-year, Price to Sales plunged 86.86% in 2022 and jumped 1006.8% in 2023.
• Over 5 years, Price to Sales stood at 18.94 in 2019, then fell by 12.14% to 16.64 in 2020, then climbed by 18.22% to 19.67 in 2021, then plunged by 76.7% to 4.58 in 2022, then slumped by 601.76% to 23.0 in 2023.
• Per Business Quant data, the three most recent Price to Sales figures were 23.0 in Q4 2023, 34.67 in Q3 2023, and 90.0 in Q2 2023.